however, some states may provide coverage for the weight loss drug for obesity treatment if deemed medically necessary
Its been used in traditional Chinese and Ayurvedic medicine for centuries, and modern research has examined its metabolic effects
In biochemical and cellular research systems, cagrilintide interacts with amylin receptors formed by calcitonin receptor complexes, activating downstream signalling pathways involved in appetite regulation, gastric emptying, and metabolic homeostasis
While these findings are promising, obesity experts emphasize that tapering and discontinuation should always be accompanied by lifestyle interventions to address root causes and sustain weight management
Apovian, MD Healio | Endocrine Today Editorial Board Member Professor of medicine Harvard Medical School Co-director, Center for Weight Management and Wellness Division of endocrinology, diabetes and nutrition Brigham and Womens Hospital, Boston Disclosures: Apovian reports advising for Novo Nordisk